{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-020843","form_type":"8-K","ticker":"GLSI","cik":"0001799788","company_name":"Greenwich LifeSciences, Inc.","filed_at":"2025-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.027912+00:00","generated_at":"2026-05-18T02:29:32.274948+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Greenwich LifeSciences dismisses RBSM, hires MaloneBailey as auditor effective July 19, 2025","bullets":["Audit committee approved dismissing RBSM LLP and engaging MaloneBailey LLP for fiscal 2025 audit.","RBSM's reports for 2024 and 2023 were unqualified; no disagreements on accounting or auditing matters.","Prior material weaknesses in internal control over financial reporting were discussed with RBSM and disclosed in earlier SEC filings.","RBSM provided a letter to the SEC, attached as Exhibit 16.1, agreeing with the Company's disclosures."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-020843","json":"https://secwatch.observer/filing/0001641172-25-020843.json","markdown":"https://secwatch.observer/filing/0001641172-25-020843.md","text":"https://secwatch.observer/filing/0001641172-25-020843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799788/000164117225020843/0001641172-25-020843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799788/000164117225020843/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T02:29:32.274948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6cf8743c04c81dea918c41cf63651603bd9a1c54","claim":"Greenwich LifeSciences, Inc. engaged MaloneBailey LLP as its auditor.","evidence_excerpt":"On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the \"Company\") approved the dismissal of RBSM LLP (\"RBSM\") as the Company's independent registered public accounting firm and approved the engagement of MaloneBailey LLP (\"MaloneBailey\") as the Company's independent registered public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799788/000164117225020843/0001641172-25-020843-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"MaloneBailey LLP"}],"fact_type":"auditor_change"},{"claim_id":"f25a5698b0909d8a546c0a5988d9117fb8a43445","claim":"Greenwich LifeSciences, Inc. dismissed RBSM LLP as its auditor.","evidence_excerpt":"On July 19, 2025, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the \"Company\") approved the dismissal of RBSM LLP (\"RBSM\") as the Company's independent registered public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799788/000164117225020843/0001641172-25-020843-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"RBSM LLP"},{"label":"Successor","value":"MaloneBailey LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}